Status:
COMPLETED
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
Lead Sponsor:
Xanodyne Pharmaceuticals
Conditions:
Pain, Postoperative
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
A multicenter study to evaluate the analgesic efficacy of XP21L in subjects with pain following bunionectomy surgery.
Eligibility Criteria
Inclusion
- 18-65 years of age
- Have undergone bunionectomy surgery
- Have achieved adequate post-surgical pain
Exclusion
- Confounding medical conditions which preclude study participation
- Participated in a study of another investigational drug or device within 30 days prior to randomization
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT00366444
Start Date
August 1 2006
Last Update
April 13 2011
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigative Site
Anaheim, California, United States, 92801
2
Investigative Site
Orange, California, United States, 92869
3
Investigative Site
Owings Mills, Maryland, United States, 21117
4
Investigative Site
Pasadena, Maryland, United States, 21122